nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CA5A—female reproductive system—ovarian cancer	0.00374	0.116	CbGeAlD
Dorzolamide—CA9—female reproductive system—ovarian cancer	0.00218	0.0678	CbGeAlD
Dorzolamide—CA9—testis—ovarian cancer	0.00176	0.0547	CbGeAlD
Dorzolamide—CA5B—gonad—ovarian cancer	0.00162	0.0504	CbGeAlD
Dorzolamide—CA12—female reproductive system—ovarian cancer	0.00161	0.0501	CbGeAlD
Dorzolamide—CA5B—female reproductive system—ovarian cancer	0.00145	0.045	CbGeAlD
Dorzolamide—CA2—embryo—ovarian cancer	0.00137	0.0425	CbGeAlD
Dorzolamide—CA5B—vagina—ovarian cancer	0.00131	0.0407	CbGeAlD
Dorzolamide—CA1—female reproductive system—ovarian cancer	0.00128	0.0397	CbGeAlD
Dorzolamide—Cardiac failure—Doxorubicin—ovarian cancer	0.00122	0.00126	CcSEcCtD
Dorzolamide—Mood swings—Epirubicin—ovarian cancer	0.00122	0.00126	CcSEcCtD
Dorzolamide—Vertigo—Paclitaxel—ovarian cancer	0.00122	0.00126	CcSEcCtD
Dorzolamide—Syncope—Paclitaxel—ovarian cancer	0.00122	0.00126	CcSEcCtD
Dorzolamide—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.00122	0.00126	CcSEcCtD
Dorzolamide—Rash—Topotecan—ovarian cancer	0.00121	0.00125	CcSEcCtD
Dorzolamide—Hypersensitivity—Vinorelbine—ovarian cancer	0.00121	0.00125	CcSEcCtD
Dorzolamide—Dermatitis—Topotecan—ovarian cancer	0.00121	0.00125	CcSEcCtD
Dorzolamide—CA1—bone marrow—ovarian cancer	0.00121	0.0375	CbGeAlD
Dorzolamide—Headache—Topotecan—ovarian cancer	0.0012	0.00125	CcSEcCtD
Dorzolamide—Palpitations—Paclitaxel—ovarian cancer	0.0012	0.00124	CcSEcCtD
Dorzolamide—Vomiting—Melphalan—ovarian cancer	0.0012	0.00124	CcSEcCtD
Dorzolamide—Loss of consciousness—Paclitaxel—ovarian cancer	0.00119	0.00123	CcSEcCtD
Dorzolamide—Pain in extremity—Doxorubicin—ovarian cancer	0.00119	0.00123	CcSEcCtD
Dorzolamide—Diplopia—Doxorubicin—ovarian cancer	0.00119	0.00123	CcSEcCtD
Dorzolamide—Rash—Melphalan—ovarian cancer	0.00119	0.00123	CcSEcCtD
Dorzolamide—Dermatitis—Melphalan—ovarian cancer	0.00119	0.00123	CcSEcCtD
Dorzolamide—Cough—Paclitaxel—ovarian cancer	0.00118	0.00122	CcSEcCtD
Dorzolamide—Asthenia—Vinorelbine—ovarian cancer	0.00118	0.00122	CcSEcCtD
Dorzolamide—Arrhythmia—Docetaxel—ovarian cancer	0.00118	0.00122	CcSEcCtD
Dorzolamide—Affect lability—Doxorubicin—ovarian cancer	0.00117	0.00121	CcSEcCtD
Dorzolamide—Hypertension—Paclitaxel—ovarian cancer	0.00117	0.00121	CcSEcCtD
Dorzolamide—CA5B—testis—ovarian cancer	0.00117	0.0363	CbGeAlD
Dorzolamide—Alopecia—Docetaxel—ovarian cancer	0.00117	0.00121	CcSEcCtD
Dorzolamide—Pruritus—Vinorelbine—ovarian cancer	0.00116	0.0012	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00116	0.0012	CcSEcCtD
Dorzolamide—Chest pain—Paclitaxel—ovarian cancer	0.00115	0.00119	CcSEcCtD
Dorzolamide—Arthralgia—Paclitaxel—ovarian cancer	0.00115	0.00119	CcSEcCtD
Dorzolamide—Anxiety—Paclitaxel—ovarian cancer	0.00115	0.00119	CcSEcCtD
Dorzolamide—Erythema—Docetaxel—ovarian cancer	0.00115	0.00119	CcSEcCtD
Dorzolamide—Nausea—Topotecan—ovarian cancer	0.00114	0.00118	CcSEcCtD
Dorzolamide—Discomfort—Paclitaxel—ovarian cancer	0.00114	0.00118	CcSEcCtD
Dorzolamide—Cardiac arrest—Doxorubicin—ovarian cancer	0.00113	0.00117	CcSEcCtD
Dorzolamide—Dry mouth—Paclitaxel—ovarian cancer	0.00113	0.00117	CcSEcCtD
Dorzolamide—Mood swings—Doxorubicin—ovarian cancer	0.00113	0.00117	CcSEcCtD
Dorzolamide—Diarrhoea—Vinorelbine—ovarian cancer	0.00113	0.00116	CcSEcCtD
Dorzolamide—Dysgeusia—Docetaxel—ovarian cancer	0.00113	0.00116	CcSEcCtD
Dorzolamide—Nausea—Melphalan—ovarian cancer	0.00112	0.00116	CcSEcCtD
Dorzolamide—Confusional state—Paclitaxel—ovarian cancer	0.00112	0.00115	CcSEcCtD
Dorzolamide—CA2—epithelium—ovarian cancer	0.00112	0.0346	CbGeAlD
Dorzolamide—Influenza—Epirubicin—ovarian cancer	0.00111	0.00115	CcSEcCtD
Dorzolamide—Back pain—Docetaxel—ovarian cancer	0.00111	0.00115	CcSEcCtD
Dorzolamide—Oedema—Paclitaxel—ovarian cancer	0.00111	0.00114	CcSEcCtD
Dorzolamide—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00111	0.00114	CcSEcCtD
Dorzolamide—Shock—Paclitaxel—ovarian cancer	0.00109	0.00113	CcSEcCtD
Dorzolamide—Dizziness—Vinorelbine—ovarian cancer	0.00109	0.00112	CcSEcCtD
Dorzolamide—Angina pectoris—Epirubicin—ovarian cancer	0.00108	0.00112	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00107	0.00111	CcSEcCtD
Dorzolamide—Bronchitis—Epirubicin—ovarian cancer	0.00107	0.00111	CcSEcCtD
Dorzolamide—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00107	0.00111	CcSEcCtD
Dorzolamide—Anorexia—Paclitaxel—ovarian cancer	0.00105	0.00109	CcSEcCtD
Dorzolamide—CA2—decidua—ovarian cancer	0.00105	0.0327	CbGeAlD
Dorzolamide—Vomiting—Vinorelbine—ovarian cancer	0.00105	0.00108	CcSEcCtD
Dorzolamide—Dysuria—Epirubicin—ovarian cancer	0.00104	0.00108	CcSEcCtD
Dorzolamide—Rash—Vinorelbine—ovarian cancer	0.00104	0.00107	CcSEcCtD
Dorzolamide—Dermatitis—Vinorelbine—ovarian cancer	0.00104	0.00107	CcSEcCtD
Dorzolamide—Hypotension—Paclitaxel—ovarian cancer	0.00103	0.00107	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.00103	0.00107	CcSEcCtD
Dorzolamide—Headache—Vinorelbine—ovarian cancer	0.00103	0.00107	CcSEcCtD
Dorzolamide—Syncope—Docetaxel—ovarian cancer	0.00103	0.00107	CcSEcCtD
Dorzolamide—Influenza—Doxorubicin—ovarian cancer	0.00103	0.00106	CcSEcCtD
Dorzolamide—Palpitations—Docetaxel—ovarian cancer	0.00102	0.00105	CcSEcCtD
Dorzolamide—Loss of consciousness—Docetaxel—ovarian cancer	0.00101	0.00104	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00101	0.00104	CcSEcCtD
Dorzolamide—Weight decreased—Epirubicin—ovarian cancer	0.00101	0.00104	CcSEcCtD
Dorzolamide—Hyperglycaemia—Epirubicin—ovarian cancer	0.001	0.00104	CcSEcCtD
Dorzolamide—Cough—Docetaxel—ovarian cancer	0.001	0.00104	CcSEcCtD
Dorzolamide—Angina pectoris—Doxorubicin—ovarian cancer	0.001	0.00104	CcSEcCtD
Dorzolamide—Insomnia—Paclitaxel—ovarian cancer	0.001	0.00103	CcSEcCtD
Dorzolamide—CA4—female reproductive system—ovarian cancer	0.000999	0.031	CbGeAlD
Dorzolamide—Paraesthesia—Paclitaxel—ovarian cancer	0.000994	0.00103	CcSEcCtD
Dorzolamide—Hypertension—Docetaxel—ovarian cancer	0.000992	0.00103	CcSEcCtD
Dorzolamide—Bronchitis—Doxorubicin—ovarian cancer	0.00099	0.00102	CcSEcCtD
Dorzolamide—Dyspnoea—Paclitaxel—ovarian cancer	0.000987	0.00102	CcSEcCtD
Dorzolamide—Somnolence—Paclitaxel—ovarian cancer	0.000984	0.00102	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000984	0.00102	CcSEcCtD
Dorzolamide—Chest pain—Docetaxel—ovarian cancer	0.000979	0.00101	CcSEcCtD
Dorzolamide—Arthralgia—Docetaxel—ovarian cancer	0.000979	0.00101	CcSEcCtD
Dorzolamide—Nausea—Vinorelbine—ovarian cancer	0.000977	0.00101	CcSEcCtD
Dorzolamide—Dyspepsia—Paclitaxel—ovarian cancer	0.000974	0.00101	CcSEcCtD
Dorzolamide—Urinary tract infection—Epirubicin—ovarian cancer	0.000964	0.000996	CcSEcCtD
Dorzolamide—Conjunctivitis—Epirubicin—ovarian cancer	0.000964	0.000996	CcSEcCtD
Dorzolamide—Dysuria—Doxorubicin—ovarian cancer	0.000963	0.000995	CcSEcCtD
Dorzolamide—Decreased appetite—Paclitaxel—ovarian cancer	0.000962	0.000994	CcSEcCtD
Dorzolamide—Dry mouth—Docetaxel—ovarian cancer	0.000957	0.000989	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000957	0.000989	CcSEcCtD
Dorzolamide—Fatigue—Paclitaxel—ovarian cancer	0.000954	0.000986	CcSEcCtD
Dorzolamide—Sweating—Epirubicin—ovarian cancer	0.000951	0.000983	CcSEcCtD
Dorzolamide—Pain—Paclitaxel—ovarian cancer	0.000946	0.000978	CcSEcCtD
Dorzolamide—Confusional state—Docetaxel—ovarian cancer	0.000946	0.000977	CcSEcCtD
Dorzolamide—CA4—bone marrow—ovarian cancer	0.000944	0.0293	CbGeAlD
Dorzolamide—Anaphylactic shock—Docetaxel—ovarian cancer	0.000938	0.000969	CcSEcCtD
Dorzolamide—Oedema—Docetaxel—ovarian cancer	0.000938	0.000969	CcSEcCtD
Dorzolamide—Epistaxis—Epirubicin—ovarian cancer	0.000936	0.000967	CcSEcCtD
Dorzolamide—Weight decreased—Doxorubicin—ovarian cancer	0.000931	0.000962	CcSEcCtD
Dorzolamide—Sinusitis—Epirubicin—ovarian cancer	0.000931	0.000962	CcSEcCtD
Dorzolamide—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000929	0.00096	CcSEcCtD
Dorzolamide—Agranulocytosis—Epirubicin—ovarian cancer	0.000926	0.000957	CcSEcCtD
Dorzolamide—Shock—Docetaxel—ovarian cancer	0.000923	0.000954	CcSEcCtD
Dorzolamide—Feeling abnormal—Paclitaxel—ovarian cancer	0.000912	0.000942	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00091	0.00094	CcSEcCtD
Dorzolamide—CA4—female gonad—ovarian cancer	0.000909	0.0282	CbGeAlD
Dorzolamide—Bradycardia—Epirubicin—ovarian cancer	0.000907	0.000937	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000905	0.000935	CcSEcCtD
Dorzolamide—Anorexia—Docetaxel—ovarian cancer	0.000894	0.000924	CcSEcCtD
Dorzolamide—Urinary tract infection—Doxorubicin—ovarian cancer	0.000892	0.000922	CcSEcCtD
Dorzolamide—Conjunctivitis—Doxorubicin—ovarian cancer	0.000892	0.000922	CcSEcCtD
Dorzolamide—Pharyngitis—Epirubicin—ovarian cancer	0.000884	0.000913	CcSEcCtD
Dorzolamide—Sweating—Doxorubicin—ovarian cancer	0.00088	0.000909	CcSEcCtD
Dorzolamide—Urticaria—Paclitaxel—ovarian cancer	0.000879	0.000908	CcSEcCtD
Dorzolamide—Hypotension—Docetaxel—ovarian cancer	0.000877	0.000906	CcSEcCtD
Dorzolamide—Abdominal pain—Paclitaxel—ovarian cancer	0.000875	0.000904	CcSEcCtD
Dorzolamide—Body temperature increased—Paclitaxel—ovarian cancer	0.000875	0.000904	CcSEcCtD
Dorzolamide—Epistaxis—Doxorubicin—ovarian cancer	0.000866	0.000895	CcSEcCtD
Dorzolamide—Sinusitis—Doxorubicin—ovarian cancer	0.000861	0.00089	CcSEcCtD
Dorzolamide—Visual impairment—Epirubicin—ovarian cancer	0.000858	0.000887	CcSEcCtD
Dorzolamide—Agranulocytosis—Doxorubicin—ovarian cancer	0.000857	0.000885	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000855	0.000883	CcSEcCtD
Dorzolamide—Insomnia—Docetaxel—ovarian cancer	0.000848	0.000877	CcSEcCtD
Dorzolamide—CA5B—lymph node—ovarian cancer	0.000847	0.0263	CbGeAlD
Dorzolamide—Paraesthesia—Docetaxel—ovarian cancer	0.000842	0.00087	CcSEcCtD
Dorzolamide—Erythema multiforme—Epirubicin—ovarian cancer	0.000842	0.00087	CcSEcCtD
Dorzolamide—Bradycardia—Doxorubicin—ovarian cancer	0.000839	0.000867	CcSEcCtD
Dorzolamide—Dyspnoea—Docetaxel—ovarian cancer	0.000836	0.000864	CcSEcCtD
Dorzolamide—Somnolence—Docetaxel—ovarian cancer	0.000834	0.000862	CcSEcCtD
Dorzolamide—Tinnitus—Epirubicin—ovarian cancer	0.00083	0.000858	CcSEcCtD
Dorzolamide—CA2—female reproductive system—ovarian cancer	0.000829	0.0257	CbGeAlD
Dorzolamide—Dyspepsia—Docetaxel—ovarian cancer	0.000826	0.000853	CcSEcCtD
Dorzolamide—Pharyngitis—Doxorubicin—ovarian cancer	0.000818	0.000845	CcSEcCtD
Dorzolamide—Decreased appetite—Docetaxel—ovarian cancer	0.000815	0.000843	CcSEcCtD
Dorzolamide—Hypersensitivity—Paclitaxel—ovarian cancer	0.000815	0.000843	CcSEcCtD
Dorzolamide—Fatigue—Docetaxel—ovarian cancer	0.000809	0.000836	CcSEcCtD
Dorzolamide—CA4—testis—ovarian cancer	0.000807	0.0251	CbGeAlD
Dorzolamide—Pain—Docetaxel—ovarian cancer	0.000802	0.000829	CcSEcCtD
Dorzolamide—Arrhythmia—Epirubicin—ovarian cancer	0.000796	0.000822	CcSEcCtD
Dorzolamide—Visual impairment—Doxorubicin—ovarian cancer	0.000794	0.000821	CcSEcCtD
Dorzolamide—Asthenia—Paclitaxel—ovarian cancer	0.000794	0.00082	CcSEcCtD
Dorzolamide—Alopecia—Epirubicin—ovarian cancer	0.000787	0.000813	CcSEcCtD
Dorzolamide—Pruritus—Paclitaxel—ovarian cancer	0.000783	0.000809	CcSEcCtD
Dorzolamide—CA2—bone marrow—ovarian cancer	0.000782	0.0243	CbGeAlD
Dorzolamide—Erythema multiforme—Doxorubicin—ovarian cancer	0.000779	0.000805	CcSEcCtD
Dorzolamide—Erythema—Epirubicin—ovarian cancer	0.000775	0.000801	CcSEcCtD
Dorzolamide—Feeling abnormal—Docetaxel—ovarian cancer	0.000773	0.000799	CcSEcCtD
Dorzolamide—Tinnitus—Doxorubicin—ovarian cancer	0.000768	0.000794	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000767	0.000793	CcSEcCtD
Dorzolamide—Tension—Epirubicin—ovarian cancer	0.000761	0.000786	CcSEcCtD
Dorzolamide—Dysgeusia—Epirubicin—ovarian cancer	0.000759	0.000784	CcSEcCtD
Dorzolamide—Diarrhoea—Paclitaxel—ovarian cancer	0.000757	0.000782	CcSEcCtD
Dorzolamide—CA2—female gonad—ovarian cancer	0.000754	0.0234	CbGeAlD
Dorzolamide—Nervousness—Epirubicin—ovarian cancer	0.000753	0.000778	CcSEcCtD
Dorzolamide—Back pain—Epirubicin—ovarian cancer	0.00075	0.000775	CcSEcCtD
Dorzolamide—CA2—vagina—ovarian cancer	0.00075	0.0233	CbGeAlD
Dorzolamide—CA1—lymph node—ovarian cancer	0.000748	0.0232	CbGeAlD
Dorzolamide—Body temperature increased—Docetaxel—ovarian cancer	0.000742	0.000766	CcSEcCtD
Dorzolamide—Abdominal pain—Docetaxel—ovarian cancer	0.000742	0.000766	CcSEcCtD
Dorzolamide—Arrhythmia—Doxorubicin—ovarian cancer	0.000736	0.000761	CcSEcCtD
Dorzolamide—Dizziness—Paclitaxel—ovarian cancer	0.000732	0.000756	CcSEcCtD
Dorzolamide—Vision blurred—Epirubicin—ovarian cancer	0.000731	0.000755	CcSEcCtD
Dorzolamide—Alopecia—Doxorubicin—ovarian cancer	0.000728	0.000752	CcSEcCtD
Dorzolamide—Erythema—Doxorubicin—ovarian cancer	0.000717	0.000741	CcSEcCtD
Dorzolamide—Tension—Doxorubicin—ovarian cancer	0.000704	0.000727	CcSEcCtD
Dorzolamide—Vomiting—Paclitaxel—ovarian cancer	0.000704	0.000727	CcSEcCtD
Dorzolamide—Dysgeusia—Doxorubicin—ovarian cancer	0.000702	0.000726	CcSEcCtD
Dorzolamide—CYP2C9—female reproductive system—ovarian cancer	0.000701	0.0218	CbGeAlD
Dorzolamide—Rash—Paclitaxel—ovarian cancer	0.000698	0.000721	CcSEcCtD
Dorzolamide—Dermatitis—Paclitaxel—ovarian cancer	0.000697	0.00072	CcSEcCtD
Dorzolamide—Nervousness—Doxorubicin—ovarian cancer	0.000697	0.00072	CcSEcCtD
Dorzolamide—Vertigo—Epirubicin—ovarian cancer	0.000697	0.00072	CcSEcCtD
Dorzolamide—Syncope—Epirubicin—ovarian cancer	0.000695	0.000718	CcSEcCtD
Dorzolamide—Back pain—Doxorubicin—ovarian cancer	0.000694	0.000717	CcSEcCtD
Dorzolamide—Headache—Paclitaxel—ovarian cancer	0.000693	0.000716	CcSEcCtD
Dorzolamide—Hypersensitivity—Docetaxel—ovarian cancer	0.000691	0.000714	CcSEcCtD
Dorzolamide—Palpitations—Epirubicin—ovarian cancer	0.000685	0.000708	CcSEcCtD
Dorzolamide—Loss of consciousness—Epirubicin—ovarian cancer	0.000681	0.000704	CcSEcCtD
Dorzolamide—Cough—Epirubicin—ovarian cancer	0.000677	0.000699	CcSEcCtD
Dorzolamide—Vision blurred—Doxorubicin—ovarian cancer	0.000676	0.000699	CcSEcCtD
Dorzolamide—Asthenia—Docetaxel—ovarian cancer	0.000673	0.000695	CcSEcCtD
Dorzolamide—Hypertension—Epirubicin—ovarian cancer	0.000669	0.000692	CcSEcCtD
Dorzolamide—CA2—testis—ovarian cancer	0.000669	0.0208	CbGeAlD
Dorzolamide—Pruritus—Docetaxel—ovarian cancer	0.000664	0.000686	CcSEcCtD
Dorzolamide—Chest pain—Epirubicin—ovarian cancer	0.00066	0.000682	CcSEcCtD
Dorzolamide—Arthralgia—Epirubicin—ovarian cancer	0.00066	0.000682	CcSEcCtD
Dorzolamide—Anxiety—Epirubicin—ovarian cancer	0.000658	0.00068	CcSEcCtD
Dorzolamide—Nausea—Paclitaxel—ovarian cancer	0.000657	0.000679	CcSEcCtD
Dorzolamide—Discomfort—Epirubicin—ovarian cancer	0.000652	0.000674	CcSEcCtD
Dorzolamide—Dry mouth—Epirubicin—ovarian cancer	0.000645	0.000667	CcSEcCtD
Dorzolamide—Vertigo—Doxorubicin—ovarian cancer	0.000644	0.000666	CcSEcCtD
Dorzolamide—Syncope—Doxorubicin—ovarian cancer	0.000643	0.000665	CcSEcCtD
Dorzolamide—Diarrhoea—Docetaxel—ovarian cancer	0.000642	0.000663	CcSEcCtD
Dorzolamide—Confusional state—Epirubicin—ovarian cancer	0.000638	0.000659	CcSEcCtD
Dorzolamide—Palpitations—Doxorubicin—ovarian cancer	0.000634	0.000655	CcSEcCtD
Dorzolamide—Oedema—Epirubicin—ovarian cancer	0.000633	0.000654	CcSEcCtD
Dorzolamide—Anaphylactic shock—Epirubicin—ovarian cancer	0.000633	0.000654	CcSEcCtD
Dorzolamide—Loss of consciousness—Doxorubicin—ovarian cancer	0.00063	0.000651	CcSEcCtD
Dorzolamide—Cough—Doxorubicin—ovarian cancer	0.000626	0.000647	CcSEcCtD
Dorzolamide—Shock—Epirubicin—ovarian cancer	0.000622	0.000643	CcSEcCtD
Dorzolamide—Dizziness—Docetaxel—ovarian cancer	0.00062	0.000641	CcSEcCtD
Dorzolamide—Hypertension—Doxorubicin—ovarian cancer	0.000619	0.00064	CcSEcCtD
Dorzolamide—Hyperhidrosis—Epirubicin—ovarian cancer	0.000612	0.000632	CcSEcCtD
Dorzolamide—Chest pain—Doxorubicin—ovarian cancer	0.000611	0.000631	CcSEcCtD
Dorzolamide—Arthralgia—Doxorubicin—ovarian cancer	0.000611	0.000631	CcSEcCtD
Dorzolamide—Anxiety—Doxorubicin—ovarian cancer	0.000609	0.000629	CcSEcCtD
Dorzolamide—Discomfort—Doxorubicin—ovarian cancer	0.000603	0.000623	CcSEcCtD
Dorzolamide—Anorexia—Epirubicin—ovarian cancer	0.000603	0.000623	CcSEcCtD
Dorzolamide—Dry mouth—Doxorubicin—ovarian cancer	0.000597	0.000617	CcSEcCtD
Dorzolamide—Vomiting—Docetaxel—ovarian cancer	0.000596	0.000616	CcSEcCtD
Dorzolamide—Rash—Docetaxel—ovarian cancer	0.000591	0.000611	CcSEcCtD
Dorzolamide—Hypotension—Epirubicin—ovarian cancer	0.000591	0.000611	CcSEcCtD
Dorzolamide—Dermatitis—Docetaxel—ovarian cancer	0.000591	0.000611	CcSEcCtD
Dorzolamide—Confusional state—Doxorubicin—ovarian cancer	0.00059	0.00061	CcSEcCtD
Dorzolamide—Headache—Docetaxel—ovarian cancer	0.000588	0.000607	CcSEcCtD
Dorzolamide—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000585	0.000605	CcSEcCtD
Dorzolamide—Oedema—Doxorubicin—ovarian cancer	0.000585	0.000605	CcSEcCtD
Dorzolamide—CA4—lymph node—ovarian cancer	0.000585	0.0182	CbGeAlD
Dorzolamide—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000576	0.000596	CcSEcCtD
Dorzolamide—Shock—Doxorubicin—ovarian cancer	0.000576	0.000595	CcSEcCtD
Dorzolamide—Insomnia—Epirubicin—ovarian cancer	0.000572	0.000591	CcSEcCtD
Dorzolamide—Paraesthesia—Epirubicin—ovarian cancer	0.000568	0.000587	CcSEcCtD
Dorzolamide—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000566	0.000585	CcSEcCtD
Dorzolamide—Dyspnoea—Epirubicin—ovarian cancer	0.000564	0.000583	CcSEcCtD
Dorzolamide—Somnolence—Epirubicin—ovarian cancer	0.000562	0.000581	CcSEcCtD
Dorzolamide—Anorexia—Doxorubicin—ovarian cancer	0.000558	0.000577	CcSEcCtD
Dorzolamide—Nausea—Docetaxel—ovarian cancer	0.000557	0.000576	CcSEcCtD
Dorzolamide—Dyspepsia—Epirubicin—ovarian cancer	0.000557	0.000575	CcSEcCtD
Dorzolamide—Decreased appetite—Epirubicin—ovarian cancer	0.00055	0.000568	CcSEcCtD
Dorzolamide—Hypotension—Doxorubicin—ovarian cancer	0.000547	0.000565	CcSEcCtD
Dorzolamide—Fatigue—Epirubicin—ovarian cancer	0.000545	0.000564	CcSEcCtD
Dorzolamide—Pain—Epirubicin—ovarian cancer	0.000541	0.000559	CcSEcCtD
Dorzolamide—CYP3A4—female reproductive system—ovarian cancer	0.000535	0.0166	CbGeAlD
Dorzolamide—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000533	0.000551	CcSEcCtD
Dorzolamide—Insomnia—Doxorubicin—ovarian cancer	0.00053	0.000547	CcSEcCtD
Dorzolamide—Paraesthesia—Doxorubicin—ovarian cancer	0.000526	0.000543	CcSEcCtD
Dorzolamide—Dyspnoea—Doxorubicin—ovarian cancer	0.000522	0.000539	CcSEcCtD
Dorzolamide—Feeling abnormal—Epirubicin—ovarian cancer	0.000521	0.000539	CcSEcCtD
Dorzolamide—Somnolence—Doxorubicin—ovarian cancer	0.00052	0.000538	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000517	0.000535	CcSEcCtD
Dorzolamide—Dyspepsia—Doxorubicin—ovarian cancer	0.000515	0.000532	CcSEcCtD
Dorzolamide—Decreased appetite—Doxorubicin—ovarian cancer	0.000509	0.000526	CcSEcCtD
Dorzolamide—Fatigue—Doxorubicin—ovarian cancer	0.000505	0.000522	CcSEcCtD
Dorzolamide—Urticaria—Epirubicin—ovarian cancer	0.000503	0.000519	CcSEcCtD
Dorzolamide—Pain—Doxorubicin—ovarian cancer	0.000501	0.000517	CcSEcCtD
Dorzolamide—Abdominal pain—Epirubicin—ovarian cancer	0.0005	0.000517	CcSEcCtD
Dorzolamide—Body temperature increased—Epirubicin—ovarian cancer	0.0005	0.000517	CcSEcCtD
Dorzolamide—CA2—lymph node—ovarian cancer	0.000485	0.0151	CbGeAlD
Dorzolamide—Feeling abnormal—Doxorubicin—ovarian cancer	0.000482	0.000498	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000479	0.000495	CcSEcCtD
Dorzolamide—Hypersensitivity—Epirubicin—ovarian cancer	0.000466	0.000482	CcSEcCtD
Dorzolamide—Urticaria—Doxorubicin—ovarian cancer	0.000465	0.000481	CcSEcCtD
Dorzolamide—Body temperature increased—Doxorubicin—ovarian cancer	0.000463	0.000478	CcSEcCtD
Dorzolamide—Abdominal pain—Doxorubicin—ovarian cancer	0.000463	0.000478	CcSEcCtD
Dorzolamide—Asthenia—Epirubicin—ovarian cancer	0.000454	0.000469	CcSEcCtD
Dorzolamide—Pruritus—Epirubicin—ovarian cancer	0.000448	0.000463	CcSEcCtD
Dorzolamide—Diarrhoea—Epirubicin—ovarian cancer	0.000433	0.000447	CcSEcCtD
Dorzolamide—Hypersensitivity—Doxorubicin—ovarian cancer	0.000431	0.000446	CcSEcCtD
Dorzolamide—Asthenia—Doxorubicin—ovarian cancer	0.00042	0.000434	CcSEcCtD
Dorzolamide—Dizziness—Epirubicin—ovarian cancer	0.000418	0.000432	CcSEcCtD
Dorzolamide—Pruritus—Doxorubicin—ovarian cancer	0.000414	0.000428	CcSEcCtD
Dorzolamide—Vomiting—Epirubicin—ovarian cancer	0.000402	0.000416	CcSEcCtD
Dorzolamide—Diarrhoea—Doxorubicin—ovarian cancer	0.000401	0.000414	CcSEcCtD
Dorzolamide—Rash—Epirubicin—ovarian cancer	0.000399	0.000412	CcSEcCtD
Dorzolamide—Dermatitis—Epirubicin—ovarian cancer	0.000399	0.000412	CcSEcCtD
Dorzolamide—Headache—Epirubicin—ovarian cancer	0.000396	0.00041	CcSEcCtD
Dorzolamide—Dizziness—Doxorubicin—ovarian cancer	0.000387	0.0004	CcSEcCtD
Dorzolamide—Nausea—Epirubicin—ovarian cancer	0.000376	0.000388	CcSEcCtD
Dorzolamide—Vomiting—Doxorubicin—ovarian cancer	0.000372	0.000385	CcSEcCtD
Dorzolamide—Rash—Doxorubicin—ovarian cancer	0.000369	0.000381	CcSEcCtD
Dorzolamide—Dermatitis—Doxorubicin—ovarian cancer	0.000369	0.000381	CcSEcCtD
Dorzolamide—Headache—Doxorubicin—ovarian cancer	0.000367	0.000379	CcSEcCtD
Dorzolamide—Nausea—Doxorubicin—ovarian cancer	0.000348	0.000359	CcSEcCtD
